Año: 2022
Journal Impact Factor (JIF): 4.5
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | 46/158 | Q2 | T1 | D3 |
HEMATOLOGY | SCIE | 25/79 | Q2 | T1 | D4 |
CELL & TISSUE ENGINEERING | SCIE | 12/29 | Q2 | T2 | D4 |
CELL BIOLOGY | SCIE | 90/191 | Q2 | T2 | D5 |
MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 61/136 | Q2 | T2 | D5 |
Año: 2022
Journal Citation Indicator (JCI): 0,910
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 44/169 | Q2 | T1 | D3 | 74,26 |
CELL & TISSUE ENGINEERING | 13/31 | Q2 | T2 | D5 | 59,68 |
CELL BIOLOGY | 68/203 | Q2 | T1 | D4 | 66,75 |
HEMATOLOGY | 24/97 | Q1 | T1 | D3 | 75,77 |
MEDICINE, RESEARCH & EXPERIMENTAL | 56/190 | Q2 | T1 | D3 | 70,79 |
Año:
2022
CiteScore:
7.600
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Transplantation | 9/51 | Q1 | T1 | D2 |
Genetics (clinical) | 21/90 | Q1 | T1 | D3 |
Oncology | 83/366 | Q1 | T1 | D3 |
Immunology and Allergy | 68/211 | Q2 | T1 | D4 |
Cancer Research | 77/214 | Q2 | T2 | D4 |
Cell Biology | 107/274 | Q2 | T2 | D4 |
Immunology | 78/217 | Q2 | T2 | D4 |
SJR año:
2022
Factor de Impacto:
1.186
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Transplantation | 10/50 | Q1 | T1 | D2 |
Genetics (clinical) | 24/99 | Q1 | T1 | D3 |
Oncology | 90/375 | Q1 | T1 | D3 |
Immunology and Allergy | 61/215 | Q2 | T1 | D3 |
Immunology | 72/226 | Q2 | T1 | D4 |
Cancer Research | 79/220 | Q2 | T2 | D4 |
Cell Biology | 98/289 | Q2 | T2 | D4 |